Sustainment：Build excellent relationship with our customers.
Possibility：Create more possibility for social contribution.
Intelligence：Use intelligence to challenge difficult issues.
Responsibility：Maintain social responsibility.
Innovation：Focusing on innovation and value creation.
Technology：Contributing to society via technology.
Provide solution to health care practitioners through our innovation medical technology as well as professional support.
Sustainability：Build excellent relationship with our customers.
Possibility：Create more opportunities for social contribution.
Intelligence：Using intelligence to challenge difficult issues.
Responsibility：Maintaining social responsibility.
Innovation：Focusing on innovation and value creation.
Technology：Contribute to society via technology.
Dermato Plastica Beauty is a company specialized in manufacturing fat transplantation kits. Our main product, Multiple Orientations Volume Adjustable Micro-Injection Device Kit (MOVAMID Kit including MAFT-Gun), with its features of ease-of-use and ergonomics in application, has been regarded as one of the most reliable kits for fat transplantation and filler injection. Rapid recovery, shorter downtime and higher fat retention rate with good long-term results are reported in thousands of cases by hundreds of experienced surgeons. This innovative medical device helps surgeons while performing such a used-to-be unpromising procedure and ensures the welfare of patients who look for a better fat grafting.
2001 Dermato Plastica Beauty Co., Ltd. was established.
2002 Beauty Shop was founded.
2003 Appointed Dr.Tsai Ming Lin to company’s consultant doctor.
2004 Appointed Dr.Tsai Ming Lin to company’s medical R&D director.
2005 Consultant Dr.Tsai Ming Lin published article of 2006 Consultant Dr.Lin received Ph.D. in 2006.
2006 Cooperative education with Charming Institute of Aesthetic& Reconstructive Surgery (CIARS).
2006 Cooperate with TOYO HAKKO CO.,LTD. to develop high antioxidant unit.
2007 Consultant Dr.Tsai Ming Lin published
2007 Taiwan patent M326838 Micro Injection Device awarded.
2009 Manufactor License approved and GMP certificate, ISO 13485:2003 certificate and CE Marking pending. U.S. patent US7,632,251 B2 awarded.
2010 GMP certificate, ISO 13485:2003 certificate and CE Marking acquired and device FDA registered and listed.
2011 China patent ZL 2010 2 0240746.7 awarded. China patent ZL 2007 1 0102727.7 awarded.
2013 U.S. patent US8,523,825 B2 awarded. Japan patent 2013-000144 awarded. Korea patent 10-1296947 awarded.
2015 New factory purchased. EU patent 11 150 723.2-1257 awarded. 2016 GMP certificate, ISO 13485:2016 certificate and CE Marking.
